Global issues in technology and medical governance have recently shown diverse developments, encompassing innovative applications of artificial intelligence (AI) in cultural heritage protection, the large-scale expansion of the semiconductor industry to meet AI computing demands, and international cooperation and reimbursement improvements for rare disease medical systems.

In the cultural sector, the integration of technology and art is changing how the public interacts with history. On the industrial front, TSMC is actively expanding its 2nm and 3nm advanced process capacity to meet the global thirst for generative AI computing power and flagship chips. Meanwhile, in the field of public health, the Taiwan Society for Pharmacoeconomics and Outcomes Research (TaSPOR) is focusing on early diagnosis and reimbursement mechanisms for rare disease treatments, emphasizing the sustainability of medical resources and patient participation.

According to public information, progress in technology and industry has entered a stage of substantial expansion. HONOR, in collaboration with the Hong Kong Maritime Museum, will utilize AI imaging technology to animate century-old paintings and other collections from September 21 to 28, 2026, aiming to increase public interest in historical artifacts through technological means. At the same time, semiconductor manufacturing leader TSMC announced that its 2026 capital expenditure is expected to reach $64 billion, fully accelerating the expansion of 2nm and 3nm wafer capacity. It is projected that capacity will see a significant increase of approximately 20% by mid-2027, with plans to commence 3nm production at its second plant in Arizona, USA, in the second half of 2027 to ensure its leading position in angstrom-node technology.

Despite significant progress in technology applications and industrial expansion, different levels of challenges and uncertainties remain in these fields. At the international political level, although high-level exchanges between the US and China continue, discussions regarding urgent issues such as security, technology, and "superintelligence" (AI)—while viewed as critical to peace and prosperity for the coming decades—show limited actual progress according to public information. Furthermore, in the medical field, the treatment of rare diseases is not merely about "having drugs available." Experts point out that ensuring medical accessibility and systemic sustainability is a core challenge that requires early diagnosis, the establishment of reasonable value assessment mechanisms, and the improvement of health insurance reimbursement systems—issues that are difficult for any single country or group to solve independently.

The aforementioned events have had a profound impact on global industrial chains and social policies. TSMC's capacity expansion directly reflects the strong competition in the global generative AI computing power demand and flagship mobile chip market; the deployment of next-generation photomask technology by partners such as ASML demonstrates the close collaboration within the semiconductor ecosystem to address the challenges of advanced processes. On a social level, the allocation of medical resources and the improvement of rare disease care systems reflect the need for countries to strike a balance between "drug accessibility" and "systemic sustainability" when facing high medical costs.

At the same time, the application of AI technology in cultural storage has provided new pathways for digital transformation in museums and history education, allowing static artifacts to engage in a dialogue with modern audiences in a dynamic form.

Regarding these developments, perspectives and limitations from all sectors must be interpreted with caution. Experts generally believe that the issue of rare diseases requires the joint participation of government, medical, academic, industrial, and patient groups to form a consensus, and cannot be solved by a single strategy. In terms of geopolitics and technology governance, although world leaders emphasize the importance of AI technology for future peace and prosperity, the setting of technical standards, cross-border regulation, and security boundaries remains a long and complex negotiation process. While the public focuses on the convenience and innovation brought by AI technology, they should not ignore the structural challenges behind these applications, such as ethics, data security, and resource allocation.

Future observations will focus on three aspects: First, the execution progress of TSMC's 2027 advanced process capacity expansion plan and the actual performance of its Arizona plant; second, whether international negotiations on "superintelligence" and AI governance can translate verbal commitments into concrete policy frameworks; and finally, whether reforms to rare disease medical reimbursement systems in Taiwan and internationally can effectively implement multi-dimensional assessment mechanisms while maintaining the long-term stability of health insurance systems while ensuring patients' rights to medication. The subsequent development of these issues will continue to influence the global technology competition landscape and social welfare.